Page 353

World Rugby Handbook

REGULATION 21 All communication must be conducted confidentially and in conformity with ADAMS. 21.7.2.2 Upon receipt of an Adverse Analytical Finding, World Rugby shall initiate a preliminary review in accordance with Regulation 21.7.2.3 to determine whether: (a) an applicable TUE has been granted or will be granted as provided in the International Standard for Therapeutic Use Exemptions, or (b) there is any apparent departure from the International Standard for Testing and Investigations or International Standard for Laboratories that caused the Adverse Analytical Finding. 21.7.2.3 The preliminary review set out in Regulation 21.7.2.2 shall be undertaken by a representative or representatives of World Rugby’s Anti-Doping Advisory Committee and/or World Rugby Anti-Doping Judicial Panel to establish if a TUE has been granted that explains the Adverse Analytical Finding or if there is any apparent departure from the International Standard for Testing and Investigations and/or if there is any apparent departure from the International Standard for Laboratories as evidenced by the documents in respect of the particular case under consideration provided by the laboratory which undermines the validity of the Adverse Analytical Finding. Such preliminary review shall, ordinarily, be completed within three days. The representative or representatives undertaking the preliminary review may make further enquiries or investigations as it or they consider appropriate solely in relation to the existence or otherwise of a TUE or apparent departures from the International Standard for Testing and Investigations and/or the International Standard for Laboratories as evidenced by the documents in respect of the particular case under consideration provided by the laboratory. If the review does reveal an applicable TUE or departure from the International Standard for Testing and Investigations and/or applicable provisions of the International Standard for Laboratories on the foregoing basis that caused the Adverse Analytical Finding, then the entire test shall be considered negative and the Player and his Union, National Anti-Doping Organisation and WADA shall be informed. 21.7.3 Notification After Preliminary Review Regarding Adverse Analytical Findings 21.7.3.1 If the preliminary review of an Adverse Analytical Finding under Regulation 21.7.2.3 does not reveal an applicable TUE or entitlement to a TUE as provided in the International Standard for Therapeutic Use Exemptions, or departure from the International Standard for Testing and Investigations or the International Standard for Laboratories that caused the Adverse Analytical Finding, World Rugby shall promptly notify the Player, and simultaneously the Player’s Union, National Anti-Doping Organisation and WADA, in the manner set out in Regulation 21.14.1, of: (a) the Adverse Analytical Finding; (b) the anti-doping rule violated; (c) the Player's right to promptly request the analysis of the B Sample or, failing such request, that the B Sample analysis may be deemed waived; (d) the scheduled date, time and place for the B Sample analysis if the Player or World Rugby chooses to request an analysis of the B Sample; (e) the Last update: 14 January, 2015 353


World Rugby Handbook
To see the actual publication please follow the link above